Cleared Abbreviated

K123556 - MORTARA SURVEYOR PATIENT MONITOR

K123556 is the FDA 510(k) clearance for MORTARA SURVEYOR PATIENT MONITOR by Mortara Instrument, Inc.. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Abbreviated 510(k) pathway after a 123-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
123d
Days
Class 2
Risk

K123556 is an FDA 510(k) clearance for the MORTARA SURVEYOR PATIENT MONITOR. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Mortara Instrument, Inc. (Milwaukee, US). The FDA issued a Cleared decision on March 22, 2013 after a review of 123 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Mortara Instrument, Inc. devices

Submission Details

510(k) Number K123556 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 19, 2012
Decision Date March 22, 2013
Days to Decision 123 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 125d · This submission: 123d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 256
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K123556.
MFM-CMS CENTRAL MONITORING SYSTEM
K120727 · Edan Instruments, Inc. · Jun 2013
SURESIGNS VM4, SURESIGNS VM6, SURESIGNS VM8
K123900 · Philips Medical Systems · Apr 2013
INFINITY CENTRALSTATION WITH INFINITY M300
K130711 · Draeger Medical Systems, Inc. · Apr 2013
INTELLIVUE PATIENT MONITOR
K122439 · Philips Medizin Systeme Boeblingen GmbH · Aug 2012
PATIENT MONITOR
K120173 · Edan Instruments, Inc. · May 2012
INFINITY ACUTE CARE SYSTEM, INFINITY MCABLE- MASIMO RAINBOW SET
K113798 · Draeger Medical Systems, Inc. · Mar 2012